MapLight Therapeutics (MPLT) Earnings Date & Reports
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MPLT is expected to report earnings to fall 26.12% to -99 cents per share on September 02
Q2'26
Est.
$-0.99
Q1'26
Missed
by $0.42
The last earnings report on May 15 showed earnings per share of -134 cents, missing the estimate of -92 cents. With 324.40K shares outstanding, the current market capitalization sits at 1.26B.